Parker, Waichman, Alonso LLP

YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)


AddThis Social Bookmark Button

Injured by Meridia?

Meridia (generic: sibutramine hci monohydrate) has been linked to side effects such as rapid heart rate, increased blood pressure, heart disease, stroke, seizure and mental impairments. Meridia is a drug that is used to treat obesity by controlling appetite.

Italy has suspended the sale of weight-loss products containing sibutramine, marketed as Meridia in the U.S. by Abbott Laboratories. Italy's Health Ministry said on March 7, 2002 that it was immediately withdrawing all sibutramine products from the market due to 50 reports of health-related problems. Although Italy was the first country to take the drugs off the market, other nations' regulatory bodies have expressed concern about sibutramine. Britain's Drug and Therapeutics Bulletin, published by the Consumers' Association, warned that the weight-loss drug had limited benefits and unwanted side effects.

In addition to the risk of cardiovasular problems, seizures, and mental impairments, it is believed that two women have died as a result of complications from the drug. Abbott Laboratories estimates that 8.6 million people have used sibutramine-based drugs since they were approved in 1997.

If you or a loved one took Meridia and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
MeridiaRSS Feed

Merida Faces European Ban

Jan 22, 2010 | Parker Waichman Alonso LLP
The same day U.S. health regulators warned that Meridia (sibutramine) shouldn’t be given to patients with a history of heart problems, their counterparts in Europe said the popular diet drug should be banned. The European Medicines Agency said that sibutramine – sold in Europe under several names, including Reductil, Reduxade and Zelium – should be pulled from the market because of associated risks of stroke and heart attack. The call for a European ban came after a study of...

Meridia Label Changes Announced

Jan 21, 2010 | Parker Waichman Alonso LLP
The U.S. Food & Drug Administration (FDA) today informed healthcare professionals that it had requested and Abbot Laboratories has agreed to add a new contraindication to the label of the weight loss drug, Meridia. The contraindication will state that Meridia is not to be used in patients with a history of cardiovascular disease, including: • History of coronary artery disease (e.g., heart attack, angina) • History of stroke or transient ischemic attack (TIA) • History of...

Meridia Faces European Scrutiny

Dec 21, 2009 | Parker Waichman Alonso LLP
Sibutramine, the prescription diet drug sold in the U.S. as Meridia, is being reviewed in Europe because it may be associated with an increased risk of heart attack and stroke.   In a press release issued December 18, the European Medicines Agency (EMEA) said it is reviewing data from  a study known as SCOUT (Sibutramine Cardiovascular Morbidity/Mortality Outcomes in Overweight or Obese Subjects at Risk of a Cardiovascular Event) that indicate an increased risk of serious...

Ban Meridia Now, Public Citizen Says

Dec 4, 2009 | Parker Waichman Alonso LLP
Meridia, a weight loss drug marketed by Abbot Laboratories, should be banned by the U.S. Food & Drug Administration (FDA) immediately, according to the consumer advocacy group Public Citizen.  In a press release announcing that it has filed its second petition with the FDA to have Meridia banned, Public Citizen said the drug has caused a significantly increased number of heart attacks, strokes, resuscitated cardiac arrests or deaths in obese patients.Meridia (sibutramine) was approved...

Meridia May Raise Risk of Heart Attacks, Strokes and Death, FDA Says

Nov 23, 2009 | Parker Waichman Alonso LLP
Meridia, Abbott Labs' popular prescription weight loss medication, may be associated with a higher risk of  heart-related side-effects, including heart attacks, strokes and death.  Over the weekend, the U.S. Food & Drug Administration (FDA) issued a Meridia Early Communication, and said it was reviewing preliminary data from a recent study that indicated patients taking Meridia for weight loss are likelier to suffer such side effects.Meridia (sibutramine) was approved by the FDA...

More Meridia News

Meridia
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you stopped taking the drug (mm-yyyy):

Date you started taking the drug (mm-yyyy):

What condition was this medication prescribed to treat?

Weight before taking Meridia:

Weight after taking Meridia:

Did you experience high blood pressure before taking Meridia?


Was blood pressure monitored while taking Meridia?


Were any of the following problems experienced while taking Meridia?






Please further describe side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2010 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising